Advancing Clinical Imaging Beyond the Existing Standard of Care: Evaluating New Optical Imaging Modalities

October 13, 2014 | State of the Market Report

A new wave of imaging technologies coupled with newly developed imaging probes are increasingly used in diagnostics, monitoring disease progression, interrogating cellular and molecular events, and assessing therapeutic efficacy in vivo. These novel technologies are largely based on optical modalities that offer an advantage of non-ionizing imaging at higher resolutions than most incumbent solutions. Used alone or coupled in novel ways with other imaging modalities, such as ultrasound, these solutions are slowly finding their way into clinical practice. Here, we look into the growing field of developers and analyze who is poised for success.

Coverage Areas

  • Digital Health and Wellness
  • Digital Transformation
  • Emerging Ecosystems in Agrifood and Health

Table of Contents

  • Title page
  • Abstract
  • Landscape
  • Analysis
  • Outlook

Lead Analyst

Milos Todorovic
Analyst

Contributors

Nicholas Kurkjy
Kevin Pang, Ph.D.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978